Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/1998
11/04/1998EP0875569A1 A human sodium dependent phosphate transporter (IPT-1)
11/04/1998EP0875568A1 Novel human neurotensin receptor type 2 and splice variants thereof
11/04/1998EP0875567A2 Mycbinding Zinc-finger proteins, preparation and use thereof
11/04/1998EP0875566A2 Novel G-protein coupled receptor (HFGAN72X)
11/04/1998EP0875565A2 Novel G-protein coupled receptor (hfgan72y)
11/04/1998EP0874910A1 Peptide-enhanced cationic lipid transfections
11/04/1998EP0874909A2 Long-term expression of gene products by transforming muscle cells
11/04/1998EP0874905A1 Novel tcts response regulator of staphylococcus aureus
11/04/1998EP0874904A1 Methods for delivering dna to muscle cells using recombinant adenoassociated virus virions
11/04/1998EP0874902A2 Compositions and methods for the treatment and diagnosis of breast cancer
11/04/1998EP0874900A1 Improved nucleic acids encoding a chimeric glycosyltransferase
11/04/1998EP0874864A1 Osteo antiviral protein
11/04/1998CN1198165A Modulators of function of FAS receptors and other proteins
11/03/1998US5831071 Using anhydrous solution of triethylamnine-hydrogen fluoride
11/03/1998US5831068 Method to increase the density of antigen on antigen presenting cells
11/03/1998US5831066 B-CELL LYMPHOMA/LEUKEMIA GENE (bcl-2); ANTISENSE AGENT COMPRISING A SYNTHETIC 18 BASE PHOSPHOROTHIOATE OLIGONUCLEOTIDE; ANTICANCER AGENT, OBLIMERSEN; ANTICANCER AGENT; SENSITIZING TUMOR CELLS TO CHEMOTHERAPY
11/03/1998US5831062 Use of the human interferon consensus gene for gene therapy
11/03/1998US5831058 Human GDP dissociation stimulating protein gene
11/03/1998US5831056 Secreted proteins and polynucleotides encoding them
11/03/1998US5831048 Grb3-3 cDNA and polypeptides
11/03/1998US5831016 Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
11/03/1998US5831008 Retinoblastoma protein-interacting zinc finger proteins
11/03/1998US5830880 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
11/03/1998US5830879 Gene transfer therapy
11/03/1998US5830878 1,2-bis(2-oleoyloxy)ethyl)-3-(2-hydroxyethyl)imidazolinium chloride
11/03/1998US5830877 Method, compositions and devices for administration of naked polynucleotides which encode antigens and immunostimulatory
11/03/1998US5830876 Genetic immunization
11/03/1998US5830858 Neurotrophic factor
11/03/1998US5830852 Compositions for insulin-receptor mediated nucleic acid delivery
11/03/1998US5830758 Binding to lymphocytes
11/03/1998US5830755 T-cell receptors and their use in therapeutic and diagnostic methods
11/03/1998US5830753 Isolated nucleic acid molecules coding for tumor rejection antigen precursor dage and uses thereof.
11/03/1998US5830745 Genetic engineered herpes virus
11/03/1998US5830730 Enhanced adenovirus-assisted transfection composition and method
11/03/1998US5830698 Kit with unique site for recombination of bacterial, insect, viral and synthetic dna
11/03/1998US5830697 P-glycoprotein mutant resistant to cyclosporin modulation
11/03/1998US5830686 Gene expression
11/03/1998US5830471 Methods and compositions comprising anti-lam-1 antibodies
11/03/1998US5830468 Fibrin(ogen) degradation by fibrinolytic matrix metalloproteinase
11/03/1998US5830463 Yeast-based delivery vehicles
11/03/1998US5830462 Regulated transcription of targeted genes and other biological events
11/03/1998US5830461 Methods for promoting wound healing and treating transplant-associated vasculopathy
11/03/1998US5830458 Method for destroying a diseased human cell
11/03/1998US5830430 Cationic lipids and the use thereof
11/01/1998CA2236128A1 Novel compounds
10/1998
10/30/1998CA2236248A1 Crfg-1a, a target and marker for chronic renal failure
10/30/1998CA2231748A1 Novel g-protein coupled receptor (hfgan72x)
10/30/1998CA2231741A1 Novel g-protein coupled receptor (hfgan72y)
10/30/1998CA2228742A1 Crfg-1, a target and marker for chronic renal failure
10/30/1998CA2228736A1 Crfg-1b, a target and marker for chronic renal failure
10/29/1998WO1998048027A2 Materials and methods for treatment of retinal diseases
10/29/1998WO1998048025A2 Regulatory system for inducible expression of genes with lambdoid promoters
10/29/1998WO1998048012A1 Fibroblasts with a foreign gene-containing composition for treating wounds
10/29/1998WO1998048009A2 Materials and methods for ribozyme treatment of retinal diseases
10/29/1998WO1998048004A1 Method and compositions for stabilizing unstable gene transcripts
10/29/1998WO1998047919A1 Materials and methods relating to stabilising substances in cells
10/29/1998WO1998047914A2 Us6 gene from the human cytomegalovirus (hcmv)
10/29/1998WO1998047361A1 Treatment for diabetes
10/29/1998WO1998039426A3 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products
10/29/1998WO1998034121A3 Isolated p27 protein and methods for its production and use
10/29/1998WO1998030696A3 Secreted proteins and polynucleotides encoding them
10/29/1998WO1998022589A3 Survivin, a protein that inhibits cellular apoptosis, and its modulation
10/29/1998CA2288292A1 Embolus therapy using insoluble microparticles or vesicles containing contrast agents
10/29/1998CA2287508A1 Materials and methods for ribozyme treatment of retinal diseases
10/29/1998CA2287495A1 Materials and methods for treatment of retinal diseases
10/29/1998CA2286612A1 Treatment for diabetes
10/29/1998CA2286548A1 Fibroblasts with a foreign gene-containing composition for treating wounds
10/28/1998EP0874054A2 Vector for the expression of immunoglobulin-cytokine fusionproteins in malignant B Cells
10/28/1998EP0874053A2 3-Dehydroquinate synthase (aroB)
10/28/1998EP0874050A2 Integrin ligand ITGL-TSP
10/28/1998EP0874047A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor
10/28/1998EP0874046A1 A novel signal transduction factor and a gene encoding the same
10/28/1998EP0873491A1 Ceramic packing with channels for thermal and catalytic beds
10/28/1998EP0873400A1 Delivery of bioactive compounds to an organism
10/28/1998EP0873360A1 Transforming growth factor alpha hiii
10/28/1998EP0873349A1 Endothelial-monocyte activating polypeptide iii
10/28/1998EP0873141A1 Compositions and methods for therapeutic use
10/28/1998EP0873138A2 Improved pharmaceutical compositions
10/28/1998EP0873049A1 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains
10/28/1998EP0774959B1 A liposomal delivery system for biologically active agents
10/28/1998CN1197077A Nucleic acid construct for cell cycle regulated expression of structural genes
10/28/1998CA2231746A1 A human sodium dependent phosphate transporter (ipt-1)
10/27/1998US5827708 Nucleotide sequence which codes for the polypeptide expressed by transfer ribonucleic acid synthetase gene; screening for antibacterial compounds; from genetically enginered cells
10/27/1998US5827703 Methods and composition for in vivo gene therapy
10/27/1998US5827702 Contacting an ocular cell with exogenous nucleic acid under conditions permissive for it uptake and expression; genetic engineering
10/27/1998US5827689 Encoding fatty acid biosynthesis (fabd) polypeptides expressed in bacterial genes; vaccines, immunology
10/27/1998US5827518 Insect immunosuppressants; insecticides
10/27/1998CA1340100C Polynucleotide commposition and method
10/24/1998CA2228743A1 Novel integrin ligand itgl-tsp
10/22/1998WO1998046781A2 Novel transgene expression system for increased persistence
10/22/1998WO1998046780A1 Novel adenoviral vectors capable of facilitating increased persistence of transgene expression
10/22/1998WO1998046779A1 Adenoviral vectors comprising a modified e4 region but retaining e4orf3
10/22/1998WO1998046778A1 Transgenomic viruses and the use thereof
10/22/1998WO1998046769A1 Composition and method for inducing an immune response against tumour-related antigens
10/22/1998WO1998046767A1 Proteins having lecithin-cholesterol acyltransferase-like activity, their production and use
10/22/1998WO1998046760A1 A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin
10/22/1998WO1998046751A1 Osteoprotegerin binding proteins and receptors
10/22/1998WO1998046750A1 flt3 LIGAND CHIMERIC PROTEINS
10/22/1998WO1998046746A1 Extracellular/epidermal growth factor like protein
10/22/1998WO1998046743A1 Novel ldl-receptor
1 ... 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 ... 870